SEOUL, April 1 (Korea Bizwire) — South Korean drugmaker Medytox Inc. said Friday it has filed a complaint with a U.S. trade panel against domestic rival botox maker Hugel Inc. over a botulinum toxin strain. The complaint lodged with the U.S. International Trade Commission (ITC) targets top South Korean botox maker Hugel, its U.S. and [...]
SEOUL, Feb. 22 (Korea Bizwire) — South Korea’s leading botox maker Hugel Inc. said Tuesday its botulinum toxin product, Letybo, has won approval from Austrian drug authorities. The Austrian Federal Office for Safety in Health Care granted the use of Letybo for the treatment of frown lines in adult patients. It marks the first time [...]
SEOUL, Feb. 11 (Korea Bizwire) — South Korea’s leading botox maker Hugel Inc. said Friday that it will make inroads into the United States, the world’s largest botulinum toxin market, this year. Earlier, the company sought a marketing authorization of its botulinum toxin product, Letybo, with the U.S. Food and Drug Administration (FDA) for the [...]
SEOUL, July 7 (Korea Bizwire) — The U.S. International Trade Commission (ITC) has sided with South Korean drugmaker Medytox Inc. in a trade dispute, saying its local rival Daewoong Pharmaceutical Co. stole secrets on a botulinum toxin strain, industry officials here said Tuesday. In its preliminary verdict, a U.S. trade judge on Monday (U.S. time) [...]
SEOUL, May 20 (Korea Bizwire) — As the ‘war on botox strains’ is escalating between Medytox Inc. and Daewoong Pharmaceutical Co., the tension between the two companies is becoming worse day by day. Medytox has filed a complaint with the U.S. International Trade Commission (USITC), accusing Daewoong of stealing the company’s botox strains. Daewoong has [...]
SEOUL, Oct. 31 (Korea Bizwire) – South Korean pharmaceutical firms Medytox and Daewoong Pharmaceuticals are heading to court to settle a dispute surrounding the use of botulinum toxin, a highly poisonous substance used to make Botox, with the South Korean media branding the legal battle as the ‘Botox War’. According to Medytox on Monday, the pharmaceutical [...]
SEOUL, Nov. 8 (Korea Bizwire) – Corporate feud over the source of a toxin strain used in Botox injections has raised safety concerns among consumers, who lay the blame on the state drug safety agency for standing akimbo even when the controversy is growing. Officials at the Ministry of Food and Drug Safety reaffirmed Tuesday [...]
SEOUL, Oct. 14 (Korea Bizwire) – The market for botulinum toxin (BTX), commonly marketed as botox, is rapidly expanding in Korea. But fierce competition between Korean botox distributors has recently intensified, with businesses questioning the safety of each other’s products. There are currently seven BTX distributors globally, three of which are Korean – Medytox, Hugel, [...]
NEW YORK, Jul. 26 (Korea Bizwire) — The worldwide reach of the International Society of Aesthetic Plastic Surgery (ISAPS) is well known to the global plastic and aesthetic surgery community. Now the release of eagerly awaited procedural survey results shows an increase of over one million reported procedures from 2014 to 2015. The data on [...]
SEOUL, July 22 (Korea Bizwire) – The battle over dentists performing botox injections between the Korean Medical Association (KMA) and the Korean Dental Association (KDA) began sometime in 2011 when a dentist named Jung was accused of violating medical laws by giving a botox injection to one of his patients. Jung attempted to use previous cases [...]